Ampio Pharmaceuticals, Inc.
(NYSE Amex Equities : AMPE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
4.92%15.151.8%$165.06m
VRXValeant Pharmaceuticals International, Inc.
2.01%21.3014.1%$125.33m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.83%154.196.2%$81.03m
PRGOPerrigo Co. Plc
1.05%46.156.8%$70.07m
SAGESAGE Therapeutics, Inc.
0.60%162.008.6%$61.94m
JAZZJazz Pharmaceuticals Plc
2.62%134.832.3%$54.72m
HZNPHorizon Pharma plc
0.60%27.006.7%$46.88m
UTHRUnited Therapeutics Corporation
2.33%81.3714.3%$44.61m
PTLAPortola Pharmaceuticals, Inc.
-0.36%30.417.5%$42.98m
ICLRICON Plc
1.32%157.174.1%$40.19m
ICPTIntercept Pharmaceuticals, Inc.
-0.99%64.0017.2%$38.64m
CTLTCatalent Inc
1.10%55.882.4%$35.42m
MDCOMedicines Company
3.78%32.7120.3%$33.51m
AERIAerie Pharmaceuticals, Inc.
-5.62%23.196.8%$25.01m
PCRXPacira Pharmaceuticals, Inc.
-1.85%38.2210.5%$24.00m

Company Profile

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.